High Island Health and subsidiary Aneros contribute more than $16,000
Washington, D.C. – March 8, 2022 – ZERO – The End of Prostate Cancer is honored to partner with High Island Health and its subsidiary Aneros, a Houston, Texas-based company providing alternative healthcare products for the treatment of benign conditions of the prostate. The “Aneros Goes Blue Campaign” this past November contributed more than $16,000 to ZERO and its mission to end prostate cancer.
“As a company with a history of over two decades in the prostate health and wellness field, we are delighted to be associated with a highly regarded organization like ZERO – The End of Prostate Cancer,” said Forrest Andrews, Product and Business Development Director of High Island Health and Aneros. “Furthermore, we’re overjoyed at the response of our customers to our special product promotion in support of this charity. It is our hope that this first donation marks the beginning of an ongoing relationship that will further the goal of bringing an end to this disease.“
High Island Health and Aneros gave a percentage of product sales to ZERO during its November “Aneros Goes Blue Campaign.” An official check presentation event was hosted in Los Angeles on February 16th with the ZERO team and Forrest Andrews.
“ZERO is honored to partner with High Island Health and Aneros to help prostate cancer patients and their families,” said Jamie Bearse, ZERO’s CEO and President. “I’m grateful for their support and ongoing commitment to men’s health and wellness. I look forward to continuing our work together.”
For more information about High Island Health and their products, visit their website at highisland.com or visit them on Twitter, Instagram, and Facebook. For more information about ZERO – The End of Prostate Cancer, visit us at zerocancer.org.
About High Island Health
High Island Health is a Houston, Texas-based company founded in 1996 by Japanese inventor Jiro Takashima dedicated to the development, manufacture and sales of alternative healthcare products for the treatment of benign conditions of the prostate. In 2000, HIH created a subsidiary, Aneros, focusing on men’s sexual health and wellness. Today, with millions of products in circulation worldwide, HIH || Aneros continues to look for new ways to make a difference in the quality of men’s lives through improved prostate health and vitality.
About ZERO — The End of Prostate Cancer
ZERO — The End of Prostate Cancer is the leading national nonprofit with the mission to end prostate cancer and help all who are impacted. ZERO advances research, provides support, and creates solutions to achieve health equity to meet the most critical needs of our community. From early detection to survivorship, ZERO is the premier resource for prostate cancer patients and their families to access comprehensive support, make meaningful connections, and take action to save lives. Our dedicated national and chapter staff is joined with a growing team of passionate volunteer champions to increase advocacy, awareness, and community engagement to ZERO out prostate cancer. ZERO is recognized with four out of four stars by Charity Navigator and accredited by the Better Business Bureau. ZERO spends more on programs than any other prostate cancer charity, dedicating 85 cents of every dollar to support, education, and research.